3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Neoplasms
1
Neoplasm Metastasis
1
Lymphatic Metastasis
1
Colorectal Neoplasms
1
Interventions
Irinotecan
11
Oxaliplatin
8
Cetuximab
7
Fluorouracil
6
Leucovorin
5
Bevacizumab
5
Standard of Care
4
S 1 (combination)
4
Capecitabine
4
trifluridine tipiracil drug combination
2
tislelizumab
2
apatinib
2
Propranolol
2
Preoperative Exercise
2
Panitumumab
2
Levoleucovorin
2
Folfox protocol
2
Etodolac
2
Endoscopic Mucosal Resection
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
trebananib
1
regorafenib
1
envafolimab
1
Trifluridine
1
Thalidomide
1
Surveys and Questionnaires
1
Occult Blood
1
Neoadjuvant Therapy
1
Moxibustion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Colorectal Neoplasms
×
Methylene Blue
×
Clear all
NCT04842968
2024-12-02
MB
St. Borbala Hospital
Phase NA
Completed
200 enrolled